Retina development continues to be driven by converging scientific, demographic, and commercial forces. With a rapidly growing patient population, and strong investor interest, there is a push for more assets into the pipeline and reshaping expectations for trial design and market access. The post Retina Development: The Next Era of Precision Therapies Is Here appeared first on Medpace Corporate .